Cart
sales@molnova.com
DMH4
CAS No. 515880-75-8
DMH4( —— )
Catalog No. M33846 CAS No. 515880-75-8
DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 53 | Get Quote |
|
| 5MG | 71 | Get Quote |
|
| 10MG | 102 | Get Quote |
|
| 25MG | 163 | Get Quote |
|
| 50MG | 241 | Get Quote |
|
| 100MG | 348 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDMH4
-
NoteResearch use only, not for human use.
-
Brief DescriptionDMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.
-
DescriptionDMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorVEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number515880-75-8
-
Formula Weight400.47
-
Molecular FormulaC24H24N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CN1CCOCC1)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hao J, et al. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol. 2010 Feb 19;5(2):245-53.??
molnova catalog
related products
-
Brivanib
A dual inhibitor of VEGFR2 and FGFR1 with IC50 of 25 nM and 148 nM respectively.
-
Bucillamine
Bucillamine protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of VEGF.
-
Telatinib
An orally active, small molecule inhibitor of VEGFR-2 (IC50=6 nM), VEGFR-3 (IC50=4 nM), PDEGFRα (IC50=15 nM) and c-Kit (IC50=1 nM) in biochemical assays.
